
10/08/2025
The FDA approved Boehringer's nerandomilast, now Jascayd, as the first new U.S. treatment for idiopathic pulmonary fibrosis in over 10 years. https://buff.ly/4pXWzaI
We are dedicated to sharing the latest news, research, and pulmonary fibrosis patient perspectives.
5307 E Mockingbird Lane
Dallas, TX
75206
Be the first to know and let us send you an email when Pulmonary Fibrosis News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
WHY YOU SHOULD CONSIDER JOINING OUR ONLINE FORUM?
It’s a safe community to connect with other patients.
You can get comprehensive updates on PF in one place.
We welcome physicians and researchers, patients and caregivers.